Background: The P2Y(1) receptor plays a key role in arterial thrombosis and is widely expressed in many cell types involved in atherosclerosis. The aim of this study was to evaluate its potential involvement in the development of atherosclerotic lesions.
Methods And Results: Apolipoprotein E-deficient (ApoE(-/-)) and P2Y(1)(-/-)/ApoE(-/-) mice were maintained on regular chow for 17 or 30 weeks before analysis of atherosclerotic lesions. At 17 weeks, lesions in the aortic sinus and entire aorta were smaller in P2Y(1)(-/-)/ApoE(-/-) compared with those in ApoE(-/-) animals. At 30 weeks, the aortic sinus lesions in P2Y(1)(-/-)/ApoE(-/-) mice were still diminished in size and displayed reduced inflammation, reflected by decreased macrophage infiltration and diminished VCAM-1 immunostaining, compared with those in ApoE(-/-) mice. They also had a lower smooth muscle cell content. Unexpectedly, bone marrow transplantation showed that the absence of the P2Y(1) receptor in blood cells only led to no significant modification of the lesion compared with control ApoE(-/-) reconstituted animals. Conversely, the absence of the P2Y(1) receptor except in blood cells resulted in a reduction in lesion size similar to that in control P2Y(1)(-/-)/ApoE(-/-) reconstituted mice, pointing to a role of non-hematopoietic-derived P2Y(1) receptors, most likely the endothelial or smooth muscle cell P2Y(1) receptors. In addition, although this was not statistically significant, plasma cholesterol levels were consistently decreased in P2Y(1)(-/-) animals, suggesting that a modification of lipid metabolism could be responsible for the observed phenotype.
Conclusions: The P2Y(1) receptor contributes to atherosclerosis, primarily through its role in non-hematopoietic-derived cells.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1161/CIRCULATIONAHA.108.788927 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Activation of PLCβ enzymes by G and G proteins is a common mechanism to trigger cytosolic Ca increase. We and others reported that G inhibitor FR900358 (FR) can inhibit both and G- and, surprisingly, G-mediated intracellular Ca mobilization. Thus, the G-G-PLCβ-Ca signaling axis depends entirely on the presence of active G, which reasonably explained FR-inhibited G-induced Ca release.
View Article and Find Full Text PDFPurinergic P2Y and P2Y receptors control enteric nervous system activity through neuro-glia-macrophage crosstalk.
Purinergic Signal
November 2024
Department of Physiology, Michigan State University, 567 Wilson Road, East Lansing, MI, 48824, USA.
Purines are important mediators of intercellular communication in the enteric nervous system (ENS) that participate in physiological gut functions and disease. Purinergic transmission is prominent in mechanisms of crosstalk between enteric neurons and glia where enteric glia exhibit high responsiveness to adenosine diphosphate (ADP) through P2Y receptors and neurons to adenosine triphosphate (ATP) through P2X receptors. Despite functional data suggesting that enteric glia are the primary site of P2Y expression in the ENS, gene sequencing suggests that P2Y expression is more enriched in neurons than glia.
View Article and Find Full Text PDFIntegrated responses of the SIP syncytium generate a major motility pattern in the colon.
J Physiol
December 2024
Department of Physiology and Cell Biology, University of Nevada, Reno School of Medicine, Reno, NV, USA.
The peristaltic reflex has been a central concept in gastrointestinal motility; however, evidence was published recently suggesting that post-stimulus responses that follow inhibitory neural responses provide the main propulsive force in colonic motility. This new concept was based on experiments on proximal colon where enteric inhibitory neural inputs are mainly nitrergic. However, the nature of inhibitory neural inputs changes from proximal to distal colon where purinergic inhibitory regulation dominates.
View Article and Find Full Text PDFSelective Inhibition of P2Y and P2Y Receptor Signal Pathways in Platelet Aggregation in Transgenic Cell Lines and Rats by Potassium 2-(1-Hydroxypentyl)-Benzoate, Puerarin and Salvianolic Acid B.
CNS Neurosci Ther
November 2024
State Key Laboratory of Bioactive Substances and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Aim: Potassium 2-(1-hydroxypentyl)-benzoate (dl-PHPB), puerarin and salvianolic acid B are three natural products or derivatives that can inhibit platelet aggregation. However, the mechanisms of dl-PHPB, puerarin and salvianolic acid B to inhibit platelet aggregation are still not clear.
Method: Here, 2-methylthioadenosine diphosphate (2-MeSADP) was used as an inducer to confirm the effects of three drugs on platelet aggregation and illustrate the corresponding mechanisms.
Modeling Platelet P2Y/ Pathway to Integrin Activation.
ArXiv
October 2024
Department of Mathematics, University of Utah, Salt Lake City, UT, 84112.
Through experimental studies, many details of the pathway of integrin activation by ADP during the platelet aggregation process have been mapped out. ADP binds to two separate G protein coupled receptors on platelet surfaces, leading to alterations in the regulation of the small GTPase RAP1. We seek to (1) gain insights into the relative contributions of both pathways to RAP1-mediated integrin activation and to (2) predict cell behavior in response to a continuous range of external agonist concentrations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!